Doctor Masaki Nakagaito
University of Toyama, Toyama (Japan)
Short-term effects of dapagliflozin versus canagliflozin on acute decompensated heart failure in patients with type 2 diabetes
Event: ESC Congress 2019
Topic: Pharmacotherapy
Session: Acute heart failure : new treatment updates
Short term effect of SGLT2 inhibitor, Dapagliflozin added on to standard therapy in decompensated heart failure patients with diabetes mellitus
Event: ESC Congress 2017
Topic: AHF - Drug treatment
Session: Fresh look at heart failure
ESC 365 is supported by
